Furthermore, results demonstrate that Glycogen synthase kinase 3‐beta (GSK3‐β), a key enzyme implicated in AD due to its role in tau protein hyperphosphorylation, can be effectively targeted by polyphenolic compounds. Here, GSK3B is linked to Alzheimer disease.